![]() |
市場調查報告書
商品編碼
1494816
到 2030 年個人化營養市場預測:按產品類型、類型、膳食計劃、分銷管道、劑型、應用和地區進行的全球分析Personalized Nutrition Market Forecasts to 2030 - Global Analysis By Product Type (Active Measurement and Standard Measurement), Type, Dietary Plan, Distribution Channel, Dosage Form, Application and By Geography |
根據 Stratistics MRC 的數據,2024 年全球個人化營養市場規模將達到 156 億美元,預計在預測期內年複合成長率為 17.5%,到 2030 年將達到 410 億美元。
個人化營養根據遺傳、新陳代謝、生活方式和健康狀況等個人特徵提出飲食建議。透過利用 DNA 測試和數位健康平台等技術,個人化營養分析個人獨特的營養需求和偏好,並提供個人化的飲食建議、飲食計畫和營養食品建議。透過考慮營養缺乏、食物不耐症和某些健康狀況的遺傳傾向等因素,個人化營養可以最佳化健康結果,預防慢性疾病,並提高整體健康水平。個人化營養採用整合科學證據、行為見解和技術創新的整體方法,使個人能夠對飲食和生活方式做出明智的選擇,並根據您的體質和健康目標促進長期健康和活力。
根據美國國立衛生研究院的數據,益生菌補充品的銷售額預計到 2023 年將達到 640 億美元以上。
提高健康意識和健康導向
隨著消費者變得更加健康意識和主動管理自己的健康,對滿足個人健康目標、偏好和飲食需求的個人化營養解決方案的需求不斷成長。隨著個人尋求客製化方法來最佳化健康和預防慢性病,個人化營養服務(包括飲食諮詢、基因檢測和飲食計劃應用程式)越來越受到人們的關注和採用。
個性化計劃高成本
個人化營養計畫的高成本可能會阻礙市場擴張和滲透新客戶群,從而限制個人化營養業務的覆蓋範圍和可擴展性。製造商、服務提供者和醫療保健專業人士可能很難在競爭激烈的市場中吸引和留住客戶,因為定價是進入壁壘,限制了個人化營養領域的收益成長和盈利。
消費者對精準醫療的興趣日益濃厚
精準醫學方法整合生物標記資料、基因檢測和其他個人化健康指標,為飲食干涉提供資訊並最佳化營養結果。消費者對個人化營養計劃越來越感興趣,這些計劃結合了生物標記分析、代謝分析和遺傳訊息,以客製化飲食建議、識別營養缺乏症並改善特定健康狀況。感性,我們正在加深對遺傳之間相互作用的理解、營養和健康。
科學依據有限
科學證據不足可能會對個人化營養市場的法律規範和品質保證帶來挑戰。監管機構在建立基於證據的標準來評估個人化營養產品和服務的安全性、有效性和準確性方面面臨著複雜的挑戰,特別是在缺乏標準化通訊協定和經過驗證的生物標記的情況下尤其如此。有限的監管監督可能會造成違規、產品標籤錯誤和消費者傷害的機會,需要監管干涉以確保消費者保護和公共健康。
COVID-19 的影響
COVID-19 大流行嚴重影響了客製化營養市場的成長。疫情期間成長速度加快,主要是由於人們健康生活方式意識的改變以及採用健康食品來增強免疫力。隨著健康問題變得越來越普遍,人們開始轉向保健食品來增強免疫力,這推動了對個人化營養食品的需求。個人化營養現在包含一種更自上而下的方法,包括檢查個人的遺傳特徵、飲食習慣、體能訓練、休息習慣、微生物組,甚至代謝率。
預計營養食品行業在預測期內將是最大的行業。
食品補充了基因檢測、生物標記分析和微生物組分析等精確營養測試方法,以幫助醫療保健專業人員和消費者了解可能影響健康結果的飲食需求和營養素,因為它使得食品產業在預測期內將成為最大的產業。膳食食品配方可以根據個人化的營養測試結果進行客製化,以滿足特定的營養需求並最佳化健康狀況。
在預測期內,錠劑領域預期年複合成長率最高
預計錠劑在預測期內的年複合成長率最高,因為它們食用安全、製造成本低且能有效提供營養。錠劑可以製造成各種形狀和尺寸。這些藥物是透過添加粉末成分製成固體片劑而開發的,該固態錠劑很容易在胃腸道中分解。此外,大多數錠劑都添加了添加劑以改善質地、外觀和風味。有些還具有塗層,以防止它們在吸收關鍵營養物質的小腸中分解。
由於領先公司的存在、政府的廣泛財政支持以及該地區研究活動的增加,預計北美在預測期內將佔據最大的市場佔有率。用於開發基於人工智慧的個人化營養平台的完善基礎設施是市場成長的關鍵因素之一。例如,2022年10月,GenoPalate, Inc.宣布透過股權融資投資560萬美元,以支持其個人化營養產品線。該公司提供線上個人化補充品和營養計劃。 GenoPalate 透過網路和行動應用程式為其營養健康資料平台提供支援。
由於其強大的產品平臺和個人化營養和補充品領域的大量患者群體,預計亞太地區在預測期內將保持最高的年複合成長率。同樣,印度正成為個人化營養和補充品市場新興企業的中心。例如,2020年4月,印度食品新興企業BhookhaHaathi推出了基於人工智慧的個人化營養服務。系統收集相關資訊並提出客製化提案。該公司正在擴大目前的營養食品業務。
According to Stratistics MRC, the Global Personalized Nutrition Market is accounted for $15.6 billion in 2024 and is expected to reach $41.0 billion by 2030 growing at a CAGR of 17.5% during the forecast period. Personalized nutrition tailors dietary recommendations to individual characteristics such as genetics, metabolism, lifestyle, and health status. Leveraging technologies like DNA testing and digital health platforms, personalized nutrition analyzes an individual's unique nutritional needs and preferences to provide personalized dietary advice, meal plans, and supplementation recommendations. By considering factors such as nutrient deficiencies, food intolerances, and genetic predispositions to certain health conditions, personalized nutrition aims to optimize health outcomes, prevent chronic diseases, and enhance overall well-being. Embracing a holistic approach that integrates scientific evidence, behavioral insights, and technological innovations, personalized nutrition empowers individuals to make informed choices about their diet and lifestyle, promoting long-term health and vitality tailored to their specific biological makeup and health goals.
According to the National Institutes of Health, the sales of probiotics supplements are projected to be more than USD 64 billion in 2023.
Rising health awareness and focus on wellness
As consumers become more health-conscious and proactive about managing their well-being, there is a growing demand for personalized nutrition solutions that cater to individual health goals, preferences, and dietary needs. Personalized nutrition services, including dietary counseling, genetic testing, and meal planning apps, experience heightened interest and adoption as individuals seek customized approaches to optimize their health and prevent chronic diseases driving the market growth.
High cost of personalized plans
High cost of personalized nutrition plans may hinder market expansion and penetration into new customer segments, limiting the reach and scalability of personalized nutrition businesses. Manufacturers, service providers, and healthcare practitioners may struggle to attract and retain customers in competitive markets where pricing is a barrier to entry, constraining revenue growth and profitability in the personalized nutrition sector.
Growing consumer interest in precision medicine
Precision medicine approaches integrate biomarker data, genetic testing, and other personalized health metrics to inform dietary interventions and optimize nutritional outcomes. Consumers are increasingly interested in accessing personalized nutrition plans that incorporate biomarker analysis, metabolic profiling, and genetic information to customize dietary recommendations, identify nutrient deficiencies, and mitigate genetic predispositions to certain health conditions, fostering a deeper understanding of the interplay between genetics, nutrition, and health.
Limited scientific evidence
Insufficient scientific evidence may pose challenges for regulatory oversight and quality assurance in the personalized nutrition market. Regulatory agencies face complexities in establishing evidence-based criteria for evaluating the safety, efficacy, and accuracy of personalized nutrition products and services, particularly in the absence of standardized protocols and validated biomarkers for assessing individual nutritional needs and responses. Limited regulatory oversight may create opportunities for noncompliance, product mislabeling, and consumer harm, necessitating regulatory interventions to ensure consumer protection and public health.
Covid-19 Impact
The pandemic of COVID-19 has had a significant impact on the tailored nutrition market's growth. The increased growth rate during the pandemic is primarily attributable to a shift in people's attitudes toward a healthy lifestyle and the adoption of health diets to promote immunity. As health problems become more prevalent, people are turning to health supplements to boost their immunity, which is driving up demand for individualized nutrition. Personalized nutrition now encompasses a more top-to-bottom approach, which involves a survey of an individual's inherited characteristics, dietary proclivities, physical movement, rest practices, micro biome, and even metabolism rates.
The nutraceuticals segment is expected to be the largest during the forecast period
The nutraceuticals is expected to be the largest during the forecast period as nutraceuticals complement precision nutrition testing methods such as genetic testing, biomarker analysis, and microbiome profiling, enabling healthcare practitioners and consumers to identify nutrient deficiencies, genetic predispositions, and metabolic imbalances that may impact dietary requirements and health outcomes. Nutraceutical formulations can be customized based on personalized nutrition test results to address specific nutrient needs and optimize health status.
The tablets segment is expected to have the highest CAGR during the forecast period
The tablets segment is expected to have the highest CAGR during the forecast period as they are safe to consume, inexpensive to produce, and effective at delivering nutrients. Tablets can be produced in various shapes and sizes. These are developed by adding powdered ingredients to create a solid tablet that can easily break down inside the digestive tract. Furthermore, most tablets have additives that enhance their texture, appearance, or taste. While others have a coating to avoid breakdown going through the small intestine the major nutrients are adsorbed.
North America is projected to hold the largest market share during the forecast period owing to the presence of major companies, extensive government funding, and an increase in research activities in the region. The presence of well-developed infrastructure for developing AI-based platforms for personalized nutrition is one of the major factors responsible for market growth. For instance, in October 2022, GenoPalate, Inc. announced an investment of USD 5.6 million through equity financing to support its product line in personalized nutrition. The company provides personalized supplements and online programs on nutrition. GenoPalate is enhancing its nutritional health data platform on the web- and mobile-based applications.
Asia Pacific is projected to hold the highest CAGR over the forecast period owing to robust product pipelines in personalized nutrition & supplements and a large patient population. Similarly, India is emerging as a hub for startups in the personalized nutrition and supplements market. For instance, in April 2020, BhookhaHaathi, an Indian nutraceutical startup, launched AI-based personalized nutrition services. The system collects relevant information to offer customized suggestions. The company is extending its current nutraceutical business.
Key players in the market
Some of the key players in Personalized Nutrition market include Amway , Arizona Nutritional Supplements, Asiamerica, Ingredients, Atlas Biomed Group Limited, Balchem Corporation, Barrington Nutritionals, BASF SE, DNA Fit, DSM, GX Sciences, LLC, Habit, LLC, Herbalife Nutrition Ltd, Maat Nutritionals, Metagenetics, Inc., Mixfix, Inc., Natures Product Inc., Nutralliance, Inc., Superior Supplement Manufacturing, Viome Life Sciences, Inc. and Wellness Coach
In May 2024, BASF expands its biomass balance portfolio for selected chemical intermediates. New range of products contribute to the replacement of fossil resources with renewable raw materials according to a certified biomass balance approach
In April 2024, Vattenfall and BASF sign purchase agreement for 49 percent of Germany's Nordlicht offshore wind farms. The two companies are deepening their partnership in the field of renewable energy
In November 2023, Acquisition of Arizona Nutritional Supplements by Founders Aaron Blunck and Jonathan Pinkus Marks a New Era of Innovation and Growth. This acquisition by its visionary founders further underscores their unwavering commitment to taking the company to new heights.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.